Pending Orexigen Sale Should Serve As A Warning Sign - Seeking Alpha

04/26/18


Pending Orexigen Sale Should Serve As A Warning Sign
Seeking Alpha
This week, Orexigen (OREX) announced that the company has received an offer to buy out the company for a total of $75 million. The offer came from Nalpropion Pharmaceuticals and the company has entered into an agreement relating to the possible sale ...

and more »

[more]